Results for tag: "Pediatric Respiratory Disease Drug"

The Pediatric Respiratory Disease Drug market is a subset of the larger Respiratory Drugs market, which includes drugs used to treat a variety of respiratory conditions. These drugs are used to treat conditions such as asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, and other respiratory diseases. Pediatric Respiratory Disease Drugs are specifically designed to treat respiratory conditions in children. These drugs are typically formulated to be more palatable and easier to administer to children than adult formulations. The Pediatric Respiratory Disease Drug market is highly competitive, with many companies offering a variety of drugs to treat pediatric respiratory conditions. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Novartis, Pfizer, and Sanofi. Other companies in the market include AstraZeneca, Boehringer Ingelheim, Cipla, and Teva Pharmaceuticals. Show Less Read more